Top Markets
#1 Glidr Glidr +51.75%
#2 DOVU DOVU +48.15%
#3 Velvet Velvet +34.29%
#4 Black Phoenix Black Phoenix +34.09%
#5 Cross Cross +30.50%
#6 Akedo Akedo +28.62%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.95%
#8 QANplatform QANplatform +14.38%
#9 Perle Perle +13.09%
#10 Bitway Bitway +12.53%
Coin of the day
Glidr Glidr
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Niki BioSolutions, Inc. Niki BioSolutions, Inc.

Niki BioSolutions, Inc.

NIKI
Clasificación en acciones #38978
Niki BioSolutions is a biopharmaceutical company that resulted from the merger... Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. The company focuses on developing and commercializing a diverse portfolio of therapeutic and diagnostic assets. Its work spans from treatments for diseases with unmet medical needs, particularly in oncology and infectious diseases, to the development of innovative, blood-based diagnostic tests for brain health and other conditions.
Precio por acción
$8.59
Capitalización bursátil
$699.54K
Cambio (1 día)
2.63%
Cambio (1 año)
-94.12%
País
US
Comercio Niki BioSolutions, Inc. (NIKI)

Categoría

Healthcare
Ratio P/S de Niki BioSolutions, Inc. (NIKI)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Niki BioSolutions, Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Niki BioSolutions, Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 -
BE